MIRABEGRON
Generic: MIRABEGRON
Qilu Pharmaceutical Co.Manufacturer
ORALRoute
MIRABEGRONActive Substance
2025-06-30Original Approval
MIRABEGRON is FDA application ANDA217989, sponsored by QILU. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
FALL
455 reports
2
DRUG INEFFECTIVE
407 reports
3
OFF LABEL USE
384 reports
4
FATIGUE
381 reports
5
DYSPNOEA
362 reports
6
DIZZINESS
331 reports
7
NAUSEA
309 reports
8
DIARRHOEA
306 reports
9
HEADACHE
297 reports
10
MALAISE
262 reports